Early Phase Clinical Trial Units (EPCTU)
Closed Solicitation Posted
This opportunity was awarded. See its 5 award notices in the notice history.
- Solicitation number
- RFP-NIAID-NIH-AI-75N93020R00023
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases seeks proposals to establish multiple Early Phase Clinical Trial Units through solicitation RFP-NIAID-NIH-AI-75N93020R00023. The clinical trial units will support Phase 0 through Phase III studies of vaccines, therapeutics, and other products for infectious diseases. Proposals will be evaluated on technical approach, personnel qualifications, project management, and facilities. The response deadline is March 26, 2021.
There is no set-aside. Services will be performed under NAICS code 541715 and PSC code R425. The minimum total contract value is $10,000, with a maximum of $346,610,277 over ten years. Proposals must separately address one of five task areas for clinical trial support.
Notice text
3 versions
Update #3 · Latest ·
This is Amendment II to Solicitation: RFP-NIAID-NIH-AI-75N93020R00023
Update #2 ·
This is Amendment I to Solicitation: RFP-NIAID-NIH-AI-75N93020R00023
Update #1 ·
Solicitation: RFP-NIAID-NIH-AI-75N93020R00023
Files
Show all 18
Notice history
| Notice | Type | Posted |
|---|---|---|
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| This notice | Solicitation | |
| Early Phase Clinical Trial Units (EPCTU) | Pre-Solicitation |
5 of 7 notices listed here. See the rest on GovTribe.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside | |
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity